Dendreon Pharmaceuticals LLC

SEAL BEACH,  CA 
United States
http://www.dendreon.com
  • Booth: 2137

Dendreon Pharmaceuticals LLC

Dendreon is a commercial-stage biopharmaceutical company and pioneer in the development of immunotherapies that are changing the future of cancer treatment. Dendreon’s flagship product, PROVENGE (sipuleucel-T), was the first FDA-approved immunotherapy made from a patient’s own immune cells. Nearly 30,000 men have been prescribed PROVENGE since its approval in 2010. Dendreon also is evaluating the use of PROVENGE in early-stage prostate cancer, with the hope of curing more men of the disease. Dendreon is headquartered in Seal Beach, Calif.

Brands: PROVENGE (sipuleucel-T) was the first FDA-approved immunotherapy made from a patient’s own immune cells and has been prescribed to more than 30,000 men with advanced prostate cancer in the U.S.